Juvenile Arthritis News

SAN FRANCISCO – Patients with uveitis related to juvenile idiopathic arthritis may benefit from therapy with Humira and background methotrexate, according to a recently presented study.

The American College of Rheumatology Annual Meeting in San Francisco begins on Nov. 7, and Healio Rheumatology will cover the event and its many topics — ranging from rheumatoid arthritis to spondyloarthropathies, osteoarthritis, systemic lupus erythematosus, scleroderma, vasculitis, fibromyalgia, juvenile arthritis and much more— throughout the week.

Welcome to the Premier Issue of Healio Rheumatology, a print publication based on the most important news as measured by the online preferences of your colleagues. In this issue, you will find the most-read content from readers of Healio.com/Rheumatology, our online news site for rheumatology. We call this unique approach to issue content selection “Peer-Tested Content” and we believe the approach will provide you the best and most valuable content in your area of expertise.

Eight physician groups from various specialties of biologics prescribers have applauded the naming convention for biosimilars proposed by the FDA as it relates to the use of separate names for biosimilars to an originator product from different manufacturers; but the groups are calling for a memorable suffix that represents the manufacturer, rather than a suffix without meaning as currently proposed.

The National Institute for Health and Care Excellence has issued final draft guidance that recommends four therapies for patients with juvenile idiopathic arthritis in the United Kingdom.

Blood levels of methotrexate polyglutamates may provide information about, adherence to and optimization of methotrexate in pediatric patients with rheumatic diseases, according to recently published data.

Patients with juvenile dermatomyositis complicated with the rapidly progressive interstitial lung disease subtype had elevated levels of B-cell activating factor and a proliferation-inducing ligand compared to patients with other subtypes of interstitial lung disease, according to a study.

Variations of a single gene region, MHC, predicted disease risk and chances of inheriting one of nine pediatric autoimmune diseases, according to the results from a genetic study published in Nature Communications.

Long-term treatment of patients with juvenile idiopathic arthritis with Orencia for up to 7 years may be beneficial, according to recently published research.

SLACK Incorporated, publisher of Healio.com, is set to expand its series of web-first news magazines delivering unique peer-tested content. Healio Rheumatology will compile the most-read content from Healio.com based on website metrics, and distribute it in a print news magazine reaching 6,100 U.S. physicians, including the universe of U.S. rheumatologists.